Cuban homeoprophylaxis

Home > Research > Research information > Research news > Cuban homeoprophylaxis

Homeopathic medicine tested on 2.3 million Cubans appears to be effective in controlling Leptospirosis epidemic

Leptospirosis is a potentially fatal infectious disease caused by exposure to contaminated water. During a 2007 epidemic in Cuba, a homeopathic medicine was given to 2.3 million people at high risk of infection, while the remaining 8.8 million population were untreated. In this study by Brach et al Bracho G et al. Large-scale application of highly-diluted bacteria for Leptospirosis epidemic control. Homeopathy, 2010; 99: 156-166, the largest-ever research study assessing a homeopathic medicine, the homeopathic treatment was “strongly associated with a drastic reduction of disease incidence resulting in complete control of the epidemic.”

Results of Cuban study Total population 11 million Rates of infection in 2007 epidemic Rates of infection in 2008 epidemic (compared with 2007)
Untreated provinces (population 8.8 million) As predicted Increase of 22%
Provinces given homeopathic treatment (population 2.3 million) Significantly lower than predicted + epidemic “completely controlled” Decrease of 84%

These results suggest Homeoprophylaxis as a ‘feasible tool for epidemic control’ and the authors call for further research.

Cuba monitors levels of Leptospirosis infection carefully and rates of disease are known to peaks during periods of heavy rainfall and flooding. In 2007 a serious epidemic began to develop in three provinces and the risk of disease was further increased by wide-spread flooding. The government was faced with the emergency situation of having only 15,000 doses of vaccine available for 2.3 million people living in high-risk areas.

Due to the extreme circumstances, the novel approach of homeoprophylaxis (HP) was attempted. A homeopathic medicine made from inactivated Leptospirosis bacteria was given to 2.3 million people at high-risk, while the remaining 8.8 million members of the population were untreated.

Within weeks of the HP intervention being given, a dramatic decrease was seen in the number of confirmed cases, from 38 to 4-6 cases per week*. The projected incidence for this period had been 111-461 cases per week, representing a decrease of between 91.8 and 65.8%. This drop occurred at the point when HP treatment had been received by 70% of the population.

The HP preparation ‘nosoLep’ was manufactured using four inactivated strains of Leptospirosis-causing bacteria. The treatment regime involved two oral doses of nosoLEP 200c given 7-9 days apart. Treatment was continued 10-12 months later with two oral doses of nosoLEP 10MC given 7-9 days apart. Each dose comprised 5 drops under the tongue (given by trained health professionals) and administered 20 mins away from eating, drinking and smoking. HP treatment was restricted to those over 1 year of age.

Homeoprophylaxis was given to 92% of the 2.3 million high-risk population; in addition to this use of the 15,000 doses of conventional vaccine included vaccination of 0.6% of the high-risk population.

*’cases per week’ means the number of cases of Leptospirosis per 100,000 people, per week.